Arkolith/Insider Trading/GANX/Form 4

Riley Jeffrey Scott

DirectorGain Therapeutics, Inc. (GANX) · full profile →Form 4 · filed Apr 1, 2024
Net Buying
Open-Market Buys
$116K
Open-Market Sells
$0
Net Open-Market Flow
$116K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 28, 2024Buy(P)30K$3.86$116K30K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-24-012340) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML